Cisplatin and Hyperthermia for Cervical Cancer
Author Information
Author(s): Wit R de, Zee J van der, Burg M E L van der, Kruit W H, Logmans A, Rhoon G C van, Verweij J
Primary Institution: Rotterdam Cancer Institute and University Hospital
Hypothesis
Can weekly cisplatin combined with local hyperthermia be effective in treating recurrent cervical cancer in previously irradiated patients?
Conclusion
The combined treatment of hyperthermia and cisplatin was well-tolerated and showed promising response rates in patients with recurrent cervical cancer.
Supporting Evidence
- Nineteen patients were treated with a median age of 47 years.
- The overall response rate was 53%, with one complete response and nine partial responses.
- No dose-limiting toxicity was observed even at the highest dose of cisplatin.
Takeaway
Doctors tested a new treatment for cervical cancer using a drug called cisplatin and heat therapy, and it worked pretty well for some patients.
Methodology
Patients received weekly cisplatin and local hyperthermia over six cycles, with temperature targets and dose levels studied.
Limitations
The study's findings need to be confirmed in a randomized trial.
Participant Demographics
Median age of participants was 47 years, with a range from 26 to 71 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website